NCT01307319
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
- Locations
-
- Teva Clinical Study Site Oxford, Alabama, United States
- Teva Clinical Study Site Bell, California, United States
- Teva Clinical Study Site Costa Mesa, California, United States
- Teva Clinical Study Site Mission Viejo, California, United States